BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 38167133)

  • 1. Tumor immune escape: extracellular vesicles roles and therapeutics application.
    Ahmadi M; Abbasi R; Rezaie J
    Cell Commun Signal; 2024 Jan; 22(1):9. PubMed ID: 38167133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicles in pancreatic cancer immune escape: Emerging roles and mechanisms.
    Liu C; He D; Li L; Zhang S; Wang L; Fan Z; Wang Y
    Pharmacol Res; 2022 Sep; 183():106364. PubMed ID: 35901939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Vesicles and Tumor-Immune Escape: Biological Functions and Clinical Perspectives.
    Raimondo S; Pucci M; Alessandro R; Fontana S
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles remodel tumor environment for cancer immunotherapy.
    Yue M; Hu S; Sun H; Tuo B; Jia B; Chen C; Wang W; Liu J; Liu Y; Sun Z; Hu J
    Mol Cancer; 2023 Dec; 22(1):203. PubMed ID: 38087360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-associated Fibroblast-derived Extracellular Vesicles Mediate Immune Escape of Bladder Cancer via PD-L1/PD-1 Expression.
    Feng R; Li Z; Ge G; Wang C; Jia Y; Ouyang J
    Endocr Metab Immune Disord Drug Targets; 2023; 23(11):1410-1420. PubMed ID: 36852791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles Mediate B Cell Immune Response and Are a Potential Target for Cancer Therapy.
    Kato T; Fahrmann JF; Hanash SM; Vykoukal J
    Cells; 2020 Jun; 9(6):. PubMed ID: 32580358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LOXL4 Shuttled by Tumor Cells-derived Extracellular Vesicles Promotes Immune Escape in Hepatocellular Carcinoma by Activating the STAT1/PD-L1 Axis.
    Zhao L; Pei R; Ding Y; Su Z; Li D; Zhu S; Xu L; Zhao H; Zhou W
    J Immunother; 2024 Feb-Mar 01; 47(2):64-76. PubMed ID: 38047403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered extracellular vesicles: A novel platform for cancer combination therapy and cancer immunotherapy.
    Ahmadi M; Hassanpour M; Rezaie J
    Life Sci; 2022 Nov; 308():120935. PubMed ID: 36075472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered extracellular vesicles and their mimetics for cancer immunotherapy.
    Liu C; Wang Y; Li L; He D; Chi J; Li Q; Wu Y; Zhao Y; Zhang S; Wang L; Fan Z; Liao Y
    J Control Release; 2022 Sep; 349():679-698. PubMed ID: 35878728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-coding RNA derived from extracellular vesicles in cancer immune escape: Biological functions and potential clinical applications.
    Huang M; Peng X; Yang L; Yang S; Li X; Tang S; Li B; Jin H; Wu B; Liu J; Li H
    Cancer Lett; 2021 Mar; 501():234-246. PubMed ID: 33186654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles mediated gastric cancer immune response: tumor cell death or immune escape?
    Yang S; Wei S; Wei F
    Cell Death Dis; 2024 May; 15(5):377. PubMed ID: 38816455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Cell-Derived Extracellular Vesicles - New Strategies in Cancer Immunotherapy.
    Yang P; Peng Y; Feng Y; Xu Z; Feng P; Cao J; Chen Y; Chen X; Cao X; Yang Y; Jie J
    Front Immunol; 2021; 12():771551. PubMed ID: 34956197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles as next generation immunotherapeutics.
    Greening DW; Xu R; Ale A; Hagemeyer CE; Chen W
    Semin Cancer Biol; 2023 May; 90():73-100. PubMed ID: 36773820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing EV communication to restore antitumor immunity.
    Massaro C; Min W; Pegtel DM; Baglio SR
    Adv Drug Deliv Rev; 2021 Sep; 176():113838. PubMed ID: 34144088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered Extracellular Vesicles to Enhance Antigen Presentation for Boosting Light-Driven Tumor Immunotherapy.
    Li X; He S; Luo B; Li P; Chen X; Wu M; Song C; Liu C; Yang T; Zhang X; Yang X; Hu J
    Small; 2023 Dec; 19(49):e2303541. PubMed ID: 37608451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering of dendritic cell bispecific extracellular vesicles for tumor-targeting immunotherapy.
    Xu F; Jiang D; Xu J; Dai H; Fan Q; Fei Z; Wang B; Zhang Y; Ma Q; Yang Q; Chen Y; Ogunnaike EA; Chu J; Wang C
    Cell Rep; 2023 Oct; 42(10):113138. PubMed ID: 37738123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicles derived from immune cells: Role in tumor therapy.
    Shi Y; Yao F; Yin Y; Wu C; Xia D; Zhang K; Jin Z; Liu X; He J; Zhang Z
    Int Immunopharmacol; 2024 May; 133():112150. PubMed ID: 38669949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular Vesicles and Their Roles in the Tumor Immune Microenvironment.
    Reale A; Khong T; Spencer A
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicle-mediated immunoregulation in cancer.
    Yamamoto T; Yamamoto Y; Ochiya T
    Int J Hematol; 2023 May; 117(5):640-646. PubMed ID: 35951282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles in immunomodulation and tumor progression.
    Marar C; Starich B; Wirtz D
    Nat Immunol; 2021 May; 22(5):560-570. PubMed ID: 33753940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.